TickerKhojComparison · NSE · data 2026-11-02
Beta Drugs Ltd. vs Panacea Biotec Limited
In plain words
Size: Beta Drugs Ltd. is about 1 times the market value of Panacea Biotec Limited.
Return on equity: Beta Drugs Ltd. 18.8% vs Panacea Biotec Limited -0.6%.
Debt to equity: Beta Drugs Ltd. 0.62 vs Panacea Biotec Limited 0.03.
Differences in the numbers, not a recommendation of either stock.
Side by side
| BETA | PANACEABIO | |
|---|---|---|
| Price | ₹1,765.5 | ₹321.9 |
| Market cap | ₹2,000 cr | ₹1,917 cr |
| P/E | 36.2 | — |
| P/B | 4.5 | — |
| ROE | 18.8% | -0.6% |
| ROCE | 16.6% | -6.3% |
| Debt / equity | 0.62 | 0.03 |
| Operating margin | 16.7% | -4.5% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 19.2% | 10.1% |
| Profit growth, 3 years (yearly) | 10.5% | — |
| 1-year return | -2.5% | -27.1% |
| Revenue, last 12 months | ₹444 cr | ₹673 cr |
| Net profit, last 12 months | ₹52 cr | ₹-7 cr |
| Latest quarter | Sept 2026 | Jun 2026 |
| Quarter net profit | ₹20 cr | ₹2 cr |
| Quarter profit vs a year earlier | — | -43.2% |
| Promoter holding | 58.91% | 72.48% |
| Health check | Strong (6.6/10) | Weak (0.8/10) |
Common questions
Which earns a higher return on equity?
Beta Drugs Ltd. (18.8% against -0.6%).
Which carries more debt?
Beta Drugs Ltd. has the higher debt-to-equity ratio (0.62 against 0.03).